These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7884959)

  • 21. Salmeterol and inhaled corticosteroids in patients with persistent asthma.
    Miller FG; Shorr AF
    JAMA; 2001 Dec; 286(24):3075-6; author reply 3077-8. PubMed ID: 11754663
    [No Abstract]   [Full Text] [Related]  

  • 22. Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy.
    Weatherall M; Wijesinghe M; Perrin K; Harwood M; Beasley R
    Thorax; 2010 Jan; 65(1):39-43. PubMed ID: 20029037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salmeterol and inhaled corticosteroids in patients with persistent asthma.
    Friedman Ross L
    JAMA; 2001 Dec; 286(24):3076; author reply 3077-8. PubMed ID: 11754664
    [No Abstract]   [Full Text] [Related]  

  • 24. Salmeterol and inhaled corticosteroids in patients with persistent asthma.
    Botkin JR; Clayton E; Nelson R; Wilfond B; Munger MA
    JAMA; 2001 Dec; 286(24):3075; author reply 3077-8. PubMed ID: 11754662
    [No Abstract]   [Full Text] [Related]  

  • 25. Bronchodilator treatment in asthma.
    Sears MR; Taylor DR
    BMJ; 1993 Aug; 307(6901):446. PubMed ID: 8374471
    [No Abstract]   [Full Text] [Related]  

  • 26. Bronchodilator treatment in asthma.
    Fuller RW; Castle WM; Palmer JB; Hall JR
    BMJ; 1993 Sep; 307(6905):683. PubMed ID: 8292148
    [No Abstract]   [Full Text] [Related]  

  • 27. Salmeterol for the treatment of asthma.
    Weinberger M
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):209-11. PubMed ID: 7552921
    [No Abstract]   [Full Text] [Related]  

  • 28. Salmeterol.
    Med Lett Drugs Ther; 1994 Apr; 36(921):37-9. PubMed ID: 7909139
    [No Abstract]   [Full Text] [Related]  

  • 29. Life-threatening asthma during treatment with salmeterol.
    Weinberger M; Abu-Hasan M
    N Engl J Med; 2006 Aug; 355(8):852-3. PubMed ID: 16929006
    [No Abstract]   [Full Text] [Related]  

  • 30. [A new long-acting asthma spray. Preliminary wait-and-see attitude?].
    Flaten O
    Tidsskr Nor Laegeforen; 1993 May; 113(13):1610. PubMed ID: 8101664
    [No Abstract]   [Full Text] [Related]  

  • 31. [The effect of time on the perception of dyspnea following inhaled long-acting bronchodilator].
    Weiner P; Magadle R; Beckerman M; Berar-Yanay N
    Harefuah; 2003 May; 142(5):342-4, 398. PubMed ID: 12803056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy, safety, and effects on quality of life of salmeterol versus albuterol in patients with mild to moderate persistent asthma.
    Wenzel SE; Lumry W; Manning M; Kalberg C; Cox F; Emmett A; Rickard K
    Ann Allergy Asthma Immunol; 1998 Jun; 80(6):463-70. PubMed ID: 9647268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Misleading data analyses in salmeterol (SMART) study.
    Lurie P; Wolfe SM
    Lancet; 2005 Oct; 366(9493):1261-2; discussion 1262. PubMed ID: 16214589
    [No Abstract]   [Full Text] [Related]  

  • 34. Lack of subsensitivity to albuterol after treatment with salmeterol in patients with asthma.
    Nelson HS; Berkowitz RB; Tinkelman DA; Emmett AH; Rickard KA; Yancey SW
    Am J Respir Crit Care Med; 1999 May; 159(5 Pt 1):1556-61. PubMed ID: 10228126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy, safety, and impact on quality of life of salmeterol in patients with moderate persistent asthma.
    Busse WW; Casale TB; Murray JJ; Petrocella V; Cox F; Rickard K
    Am J Manag Care; 1998 Nov; 4(11):1579-87. PubMed ID: 10338904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salmeterol and paroxetine: more evidence for paradoxical medicine.
    Yun AJ; Lee PY; Doux JD
    Med Hypotheses; 2006; 66(5):1037-8. PubMed ID: 16364562
    [No Abstract]   [Full Text] [Related]  

  • 37. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FDA panel: ban 2 popular asthma drugs.
    Kuehn BM
    JAMA; 2009 Jan; 301(4):365-6. PubMed ID: 19176431
    [No Abstract]   [Full Text] [Related]  

  • 39. Excess mortality in patients with asthma on long-acting beta2-agonists.
    Hasford J; Virchow JC
    Eur Respir J; 2006 Nov; 28(5):900-2. PubMed ID: 17074917
    [No Abstract]   [Full Text] [Related]  

  • 40. Salmeterol xinafoate in children on high dose inhaled steroids.
    Russell G; Williams DA; Weller P; Price JF
    Ann Allergy Asthma Immunol; 1995 Nov; 75(5):423-8. PubMed ID: 7583864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.